15 Jun 2026 | Press release
We are pleased to share an important milestone for Technophage: the Phase 1/2a clinical study TP-122_101A has recently received the necessary regulatory approvals to move forward in Europe, specifically Portugal and the Netherlands. The study, entitled...
